Theranosis Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.88 Cr
- Paid Up Capital ₹ 1.73 Cr
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2018
- Revenue Growth %
- Ebitda
- Net Worth 1063.75%
- Total Assets 822.93%
About Theranosis Life Sciences
Theranosis Life Sciences Private Limited (TLSPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 05 February 2016 (Eight years and 11 months 28 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 1.88 Cr and a paid-up capital of Rs 1.73 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shibichakravarthy Kannan and Vennila serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U85191TG2016PTC103127
-
Company No.
103127
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Feb 2016
-
Date of AGM
28 Sep 2018
-
Date of Balance Sheet
31 Mar 2018
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Theranosis Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shibichakravarthy Kannan
|
Director | 05-Feb-2016 | Current |
|
Vennila
|
Director | 11-Dec-2017 | Current |
Financial Performance of Theranosis Life Sciences.
Theranosis Life Sciences Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 1063.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Theranosis Life Sciences?
In 2018, Theranosis Life Sciences had a promoter holding of 99.99% and a public holding of 0.02%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Episteme Genomics Private LimitedShibichakravarthy Kannan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Theranosis Life Sciences?
Unlock and access historical data on people associated with Theranosis Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Theranosis Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Theranosis Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
